Dong Soo Yu

ORCID: 0000-0002-2196-949X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immune Response and Inflammation
  • Immune Cell Function and Interaction
  • Cancer and Skin Lesions
  • Nonmelanoma Skin Cancer Studies
  • Antimicrobial Peptides and Activities
  • Dermatology and Skin Diseases
  • Reconstructive Facial Surgery Techniques
  • Immunotherapy and Immune Responses
  • Nail Diseases and Treatments
  • RNA Interference and Gene Delivery
  • Ear and Head Tumors
  • Contact Dermatitis and Allergies
  • Asthma and respiratory diseases
  • Skin Protection and Aging
  • Reconstructive Surgery and Microvascular Techniques
  • Cancer-related Molecular Pathways
  • Cutaneous Melanoma Detection and Management
  • Facial Rejuvenation and Surgery Techniques
  • Psoriasis: Treatment and Pathogenesis
  • melanin and skin pigmentation
  • Oral Health Pathology and Treatment
  • Autoimmune Bullous Skin Diseases
  • Dermatologic Treatments and Research
  • Nasal Surgery and Airway Studies
  • Cutaneous lymphoproliferative disorders research

Uijeongbu St. Mary's Hospital
2005-2024

Catholic University of Korea
2015-2024

Seoul St. Mary's Hospital
2021

Soochow University
2017-2020

Idera Pharmaceuticals (United States)
2007-2015

Gyeonggi Research Institute
2014

Massachusetts General Hospital
2007

St. Paul's Hospital
2006

University of Massachusetts Chan Medical School
2003

Dongguk University
2003

Abstract Photothermal therapy (PTT) is of particular importance as a highly potent therapeutic modality in cancer therapy. However, critical challenge still remains the exploration effective strategy to maximize PTT efficiency due tumor thermoresistance and thus frequent recurrence. Here, rational fabrication micelles that can achieve mutual synergy molecularly targeted (MTT) for ablation reported. The generate both distinct photothermal effect from Cypate through enhanced conversion...

10.1002/adfm.201702834 article EN Advanced Functional Materials 2017-09-05

Psoriasis is a chronic inflammatory skin disease that involves the induction of T-helper 1 (Th1) and 17 (Th17) cell responses aberrant expression proinflammatory cytokines, including IL-1β. Copious evidence suggests abnormal activation Toll-like receptors (TLRs) contributes to initiation maintenance psoriasis. We have evaluated an antagonist TLR7, 8, 9 as therapeutic agent in IL-23-induced psoriasis model mice. Psoriasis-like lesions were induced C57BL/6 mice by intradermal injection IL-23...

10.1038/jid.2013.57 article EN publisher-specific-oa Journal of Investigative Dermatology 2013-01-31

Bacterial DNA and synthetic oligomers containing CpG dinucleotides activate the immune system through Toll-like receptor (TLR) 9. Here, we compare immunostimulatory activity of three immunomers with different nucleotide sequences a cytosine-phosphate-2'-deoxy-7-deazaguanosine dinucleotide (CpR), called immunomodulatory oligonucleotides (IMOs), in mouse, human, monkey systems. IMOs induced IL-12 IFN-gamma secretion more than control non-CpG IMO mice. All activated HEK293 cells expressing TLR9...

10.1073/pnas.0501729102 article EN Proceedings of the National Academy of Sciences 2005-04-28

Oligonucleotides containing an immune-stimulatory motif and immune-regulatory act as antagonists of Toll-like receptor (TLR)7 TLR9. In the present study, we designed synthesized oligonucleotide-based TLR7, 8 9 a 7-deaza-dG or arabino-G modification in 2′-O-methylribonucleotides motif. We evaluated biological properties these novel synthetic oligoribonucleotides TLRs 7, murine human cell-based assays vivo mice non-human primates. HEK293, mouse assays, antagonist compounds inhibited signaling...

10.1093/nar/gkt078 article EN cc-by-nc Nucleic Acids Research 2013-02-08

Cutaneous dermatophyte infections, dermatophytosis, are common worldwide, affecting various age groups and body parts. Despite advancements in antifungal therapies, the prevalence of dermatophytosis continues to increase, posing significant challenges for diagnosis treatment. This review provides an overview prevalence, clinical features, diagnostic methods Korea. A comprehensive domestic reports research on Korea was conducted using data from KoreaMed. study covers presentations,...

10.5145/acm.2025.28.1.1 article EN Annals of Clinical Microbiology 2025-01-03

Bacterial DNA and synthetic oligonucleotides containing unmethylated CpG dinucleotides (CpG DNA) activate the vertebrate immune system promote Th1-like responses. Several DNAs are currently being tested in clinical trials as either alone or combination with vaccines, antibodies, allergens separately conjugates for a number of disease indications including cancers, allergies, asthma. In this paper, we show that conjugation an oligonucleotide through their 5'-ends (5'-5'-linked significantly...

10.1021/bc0200374 article EN Bioconjugate Chemistry 2002-08-28

Viral and synthetic single-stranded RNAs are the ligands for Toll-like receptor (TLR)7 TLR8. However, RNA is rapidly degraded by ubiquitous RNases, studies reported to date have used with lipid carriers. To overcome nuclease susceptibility of RNA, we synthesized several incorporating a range chemical modifications. The present study describes one pool compounds, referred as stabilized immune modulatory (SIMRA) in which two segments attached through their 3' ends. SIMRA compounds showed...

10.1073/pnas.0706059104 article EN Proceedings of the National Academy of Sciences 2007-08-15

Oligodeoxynucleotides (ODNs) containing unmethylated CpG dinucleotides act as agonists of TLR9 and induce Th1-type immune responses. In the present study, we synthesized ODNs in which C or G was substituted with 2'-O-methylribonucleotides, 5-methyl-dC, 2'-O-methyl-5-methyl-C studied their stimulatory activity alone combination TLR agonists. mouse human primary cell-based assays, modified did not stimulate responses but inhibited agonist-induced activity. mice, cytokines induced by TLR7 TLR9....

10.1021/jm900730r article EN Journal of Medicinal Chemistry 2009-08-03

Abstract BACKGROUND MDM2 oncogene is overexpressed in many human cancers including prostate cancer and levels are associated with poor prognosis. This study was undertaken to investigate the functions of growth value as a drug target for therapy by inhibiting expression. METHODS Antisense anti‐human‐MDM2 mixed‐backbone oligonucleotide its mismatch control were tested vitro vivo models (LNCaP, DU 145, PC‐3) anti‐tumor activity. Targeted gene products related proteins analyzed activity...

10.1002/pros.10187 article EN The Prostate 2002-12-20

Hypoxia is widely accepted as a fundamental biological phenomenon, which strongly associated with tissue damage and cell viability under stress conditions. Insulin-like growth factor‑1 (IGF‑1) known to protect tissues from multiple types of damage, cells apoptosis. regulatory factor the IGF system, however role IGF-1 receptor (IGF‑1R) in hypoxia‑induced apoptosis remains unclear. The present study investigated potential mechanisms IGF‑1R‑associated hypoxic Mouse embryonic fibroblasts...

10.3892/mmr.2017.6265 article EN cc-by-nc-nd Molecular Medicine Reports 2017-03-01

Bacterial and synthetic DNAs containing CpG dinucleotides in specific sequence contexts activate the vertebrate immune system through Toll-like receptor 9 (TLR9). In present study, we used a nucleoside with bicyclic heterobase [1-(2′-deoxy-β- d -ribofuranosyl)-2-oxo-7-deaza-8-methyl-purine; R] to replace C CpG, resulting an RpG dinucleotide. The dinucleotide was incorporated mouse- human-specific motifs oligodeoxynucleotides (oligos) 3′-3-linked oligos, referred as immunomers. Oligos motif...

10.1073/pnas.2335947100 article EN Proceedings of the National Academy of Sciences 2003-11-10

Abstract Purpose: The MDM2 oncogene, amplified or overexpressed in many human cancers, has been suggested to be a novel target for cancer therapy. We have demonstrated second-generation antisense antihuman-MDM2 oligonucleotide antitumor activity when administered alone combination with chemotherapeutic agents. In the present study, we investigated effect of on radiation Experimental Design: vitro radiosensitization was determined cell lines cancers prostate (LNCaP and PC3), breast (MCF-7...

10.1158/1078-0432.ccr-0245-03 article EN Clinical Cancer Research 2004-02-15

Oligodeoxyribonucleotides containing unmethylated CpG motifs act as TLR9 agonists. In this study, we evaluated oligonucleotides an motif in which two nucleotides adjacent to the dinucleotide were substituted with 2'-O-methylribonucleotides, resulting TLR7 and antagonists. mouse human cell cultures, antagonists did not stimulate immune activation but inhibited agonist-induced activity. mice, responses induced by agonists for up several days, inhibition was dose-dependent. Antagonists also...

10.1021/jm8014316 article EN Journal of Medicinal Chemistry 2008-12-22

Abstract Viral and synthetic single-stranded RNAs are the ligands for Toll-like receptors 7 8 (TLR7 TLR8). We have reported a novel class of oligoribonucleotides, referred to as stabilized immune-modulatory RNA compounds, which act agonists TLR7, TLR8, or both TLR7 TLR8 depending on sequence composition presence specific chemical modifications. In present study, we evaluated antitumor activity dual TLR7/8 agonist in tumor-bearing mice with peritoneal disseminated CT26.CL25 colon 3LL-C75 lung...

10.1158/1535-7163.mct-09-1198 article EN Molecular Cancer Therapeutics 2010-06-01

We evaluated the recent trend in incidence of premalignant and malignant skin lesions between 1991 2006. Among 571,057 newly registered dermatology out-patients from our 8 affiliated university hospitals, 2,598 were diagnosed with a (899, 0.16%) or (1,699, 0.30%). Of 899 cases, 71.2% actinic keratosis (AK), 24.6% Bowen's disease. 1,699 46.2% basal cell carcinoma, followed by squamous carcinoma (19.1%) melanoma (7.1%). This 16-yr survey was divided equally into two time periods to compare at...

10.3346/jkms.2010.25.6.924 article EN cc-by-nc Journal of Korean Medical Science 2010-01-01

Ultraviolet radiation causes skin damage due to increased production of reactive oxygen species (ROS) and inflammatory intermediates direct attack DNA cells. Astaxanthin is a reddish pigment that belongs group chemicals called carotenoids has protective effects as an antioxidant.To determine the beneficial astaxanthin on damaged human after exposure ultraviolet radiation.Normal epidermal keratinocytes (NHEKs) were pre-treated with for 24 hours exposed B (UVB) irradiation. After hours, Cell...

10.5021/ad.2022.34.2.125 article EN Annals of Dermatology 2022-01-01

The MDM2 oncogene is amplified or overexpressed in many human cancers and levels are associated with poor prognosis. not only serves as a negative regulator of p53 but also has p53-independent activities. This study investigates the functions colon cancer growth potential value drug target for therapy, by inhibiting expression an antisense anti-human-MDM2 oligonucleotide.The selected mixed-backbone oligonucleotide was evaluated its vitro vivo antitumor activity models: LS174T cell line...

10.1007/bf03402011 article EN cc-by Molecular Medicine 2002-04-01

Background: Balneotherapy, although not a well-established dermatological treatment, is thought to have therapeutic properties for psoriasis and used as an alternative treatment modality throughout the world.Objective: To evaluate mechanism underlying immunologic effects of thermomineral water.Methods: A murine model imiquimod-induced psoriasis-like skin inflammation was evaluating balneotherapy with Hae-Un-Dae hot spring mineral water.The clinical improvements were evaluated by...

10.5021/ad.2014.26.2.221 article EN cc-by-nc Annals of Dermatology 2014-01-01

A 64-year-old female presented with facial hyperpigmentation. She had dyed her hair monthly pure henna powder for the past seven months. After patch tests, patient was diagnosed as post-inflammatory hyperpigmentastion due to allergic contact dermatitis that has rarely been reported. The underwent Q-switched Nd:YAG laser treatment and treated oral tranexamic acid 10 weeks. hyperpigmentation on forehead demonstrated substantial improvement.

10.3109/14764172.2015.1114634 article EN Journal of Cosmetic and Laser Therapy 2016-01-06
Coming Soon ...